Recommendations for the use of long-term central venous catheter (CVC) in children with hemato-oncological disorders: management of CVC-related occlusion and CVC-related thrombosis. On behalf of the coagulation defects working group and the supportive therapy working group of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Paola GiordanoPaola SaraccoAngelo Claudio Molinari Review Article 25 August 2015 Pages: 1765 - 1776
Anemia among Muslim Bedouin and Jewish women of childbearing age in Southern Israel Yulia Treister-GoltzmanRoni PelegAya Biderman Original Article 28 July 2015 Pages: 1777 - 1784
Incidence of testicular microlithiasis in patients with β-thalassemia major Rahil RahimiAmin Abolhasani ForoughiMehran Karimi Original Article 08 August 2015 Pages: 1785 - 1789
Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results Francisco CervantesIgnacio M. IsolaArturo Pereira Original Article 28 June 2015 Pages: 1791 - 1796
Transfusion dependency at diagnosis and transfusion intensity during initial chemotherapy are associated with poorer outcomes in adult acute myeloid leukemia Giovanna CannasJihane FattoumXavier Thomas Original Article 23 July 2015 Pages: 1797 - 1806
Cytotoxic effects of high concentrations of sodium ascorbate on human myeloid cell lines Domenico MastrangeloLauretta MassaiGiovanni Grasso Original Article 12 August 2015 Pages: 1807 - 1816
Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival Lan YuanLing LuLiming Bao Original Article 05 September 2015 Pages: 1817 - 1828
Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients Yinjun LouYafang MaJie Jin Original Article 22 August 2015 Pages: 1829 - 1837
Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment Felicitas HitzJ. M. ConnorsR. Klasa Original Article 07 August 2015 Pages: 1839 - 1843
Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial Byeong-Bae ParkWon Seog KimWon Sik Lee Original Article 08 August 2015 Pages: 1845 - 1851
The influence of rituximab, high-dose therapy followed by autologous stem cell transplantation, and age in patients with primary CNS lymphoma M. MadleI. KrämerM. Witzens-Harig Original Article 14 August 2015 Pages: 1853 - 1857
Liposomal cytarabine in prophylaxis or curative treatment of central nervous system involvement in Burkitt leukemia/lymphoma Amandine SegotEmmanuel RaffouxThomas Cluzeau Original Article 18 August 2015 Pages: 1859 - 1863
Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP Yu WangYa-Jun LiZhi-Ming Li Original Article 02 September 2015 Pages: 1865 - 1873
Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents A. RomanoN. L. ParrinelloI. Borrello Original Article 31 July 2015 Pages: 1875 - 1883
Clinical and echocardiographic characteristics for differentiating between transthyretin-related and light-chain cardiac amyloidoses Minako MoriYoshimori AnKazunori Imada Original Article 08 August 2015 Pages: 1885 - 1890
Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome Agnieszka PiekarskaLidia GilAndrzej Hellmann Original Article Open access 29 July 2015 Pages: 1891 - 1897
Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation A. Tschan-PlesslJ. P. HalterS. Gerull Original Article 02 August 2015 Pages: 1899 - 1905
Preemptive administration of human αβ T cell receptor-targeting monoclonal antibody GZ-αβTCR potently abrogates aggressive graft-versus-host disease in vivo Gregor BlankChristian WelkerKarin Schilbach Original Article 13 August 2015 Pages: 1907 - 1919
Is a liver-spleen scan helpful in the evaluation of patients with thrombocytopenia? Kartik AnandReinhold Munker Letter to the Editor 15 July 2015 Pages: 1921 - 1922
Deletion of SPRY4 is a frequent event in secondary acute myeloid leukemia Olivia GeigerStefan HatzlArmin Zebisch Letter to the Editor 25 July 2015 Pages: 1923 - 1924
Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome Che-Hung LinSu-Peng YehTze-Yi Lin Letter to the Editor 02 August 2015 Pages: 1925 - 1926
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene Elisa RumiJelena D. MilosevicMario Cazzola Letter to the Editor 23 July 2015 Pages: 1927 - 1928
JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinib Anne KoehlerKarolin HubertHaifa Kathrin Al-Ali Letter to the Editor 23 July 2015 Pages: 1929 - 1930
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study Sara BigliardiMonica MorselliFabio Forghieri Letter to the Editor 25 July 2015 Pages: 1931 - 1934
Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma Naoto TomitaMasataka TaguriYoshiaki Ishigatsubo Letter to the Editor 25 July 2015 Pages: 1935 - 1937
Disseminated extranodal marginal zone lymphoma involving the gastrocnemius muscle with sural neurolymphomatosis Pooja AdvaniLiuyan JiangJames Foran Letter to the Editor 22 July 2015 Pages: 1939 - 1940
MYD88 mutation analysis of a rare composite chronic lymphocyte leukemia and lymphoplasmacytic lymphoma by flow cytometry cell sorting Min ShiStephen SpurgeonGuang Fan Letter to the Editor 02 August 2015 Pages: 1941 - 1944